Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
CALL
Boston Properties
BXP
$11.2B
| $2.04M | ﹤0.01% |
35,500
+8,000
| +29% | +$416K |
|
3402
Beyond Meat
BYND
$292M
| $2.04M | ﹤0.01% |
157,362
+33,435
| +27% | +$425K |
|
3403
Cullinan Oncology
CGEM
$1.01B
| $2.03M | ﹤0.01% |
189,073
-55,480
| -23% | -$589K |
|
3404
Invivyd
IVVD
$158M
| $2.03M | ﹤0.01% |
1,935,875
+409,716
| +27% | +$523K |
|
3405
Bionano Genomics
BNGO
$12.3M
| $2.03M | ﹤0.01% |
+5,551
| New | +$2.51M |
|
3406
CALL
Axsome Therapeutics
AXSM
$11.2B
| $2.03M | ﹤0.01% |
+28,200
| New | +$2.08M |
|
3407
Thor Industries
THO
$3.9B
| $2.02M | ﹤0.01% |
19,551
+5,022
| +35% | +$424K |
|
3408
The Honest Company
HNST
$402M
| $2.02M | ﹤0.01% |
1,203,699
+1,098,297
| +1,042% | +$1.87M |
|
3409
Anavex Life Sciences
AVXL
$255M
| $2.02M | ﹤0.01% |
248,297
+169,649
| +216% | +$1.45M |
|
3410
PJT Partners
PJT
$4.3B
| $2.02M | ﹤0.01% |
+28,977
| New | +$2M |
|
3411
CALL
Lattice Semiconductor
LSCC
$17.6B
| $2.02M | ﹤0.01% |
+21,000
| New | +$1.81M |
|
|
PTVE
3412
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.02M | ﹤0.01% |
266,444
+142,837
| +116% | +$1.09M |
|
3413
Synaptics
SYNA
$4.19B
| $2.02M | ﹤0.01% |
23,616
+2,509
| +12% | +$218K |
|
|
TIXT
3414
DELISTED
TELUS International
TIXT
| $2.01M | ﹤0.01% |
+132,721
| New | +$2.31M |
|
|
PSTX
3415
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.01M | ﹤0.01% |
1,144,351
+168,739
| +17% | +$431K |
|
|
PVBC
3416
DELISTED
Provident Bancorp
PVBC
| $2.01M | ﹤0.01% |
243,136
+221,361
| +1,017% | +$1.67M |
|
|
BCYC
3417
Bicycle Therapeutics
BCYC
$269M
| $2.01M | ﹤0.01% |
78,759
+61,923
| +368% | +$1.44M |
|
3418
Virgin Galactic
SPCE
$328M
| $2.01M | ﹤0.01% |
25,894
-43,932
| -63% | -$3.48M |
|
3419
Bluerock Homes Trust
BHM
$35.3M
| $2.01M | ﹤0.01% |
124,495
+54,163
| +77% | +$933K |
|
3420
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $2.01M | ﹤0.01% |
136,935
-44,147
| -24% | -$699K |
|
3421
PUT
IAMGOLD
IAG
$8.2B
| $2M | ﹤0.01% |
760,400
-280,400
| -27% | -$812K |
|
3422
PUT
XP
XP
$8.81B
| $1.99M | ﹤0.01% |
+85,000
| New | +$1.44M |
|
3423
CALL
Viking Therapeutics
VKTX
$3.7B
| $1.99M | ﹤0.01% |
123,000
-212,300
| -63% | -$4.45M |
|
|
INFN
3424
DELISTED
Infinera Corporation Common Stock
INFN
| $1.99M | ﹤0.01% |
411,858
-3,061,263
| -88% | -$16.8M |
|
3425
CALL
Warner Bros
WBD
$65.9B
| $1.99M | ﹤0.01% |
158,600
+115,500
| +268% | +$1.5M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.